Performance vs S&P 500

03
Tracked Q1 2025–Q3 2025 -7.8%
S&P 500 total return (same window) +21.3%
Excess return -29.0%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 1 positions

05
Type Streak 8Q trend
RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock $65,558,755 100.00% 13,434,171 $-2,418,151

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
RXRX Price move only +0 -$2.4M